Identifies risk of developing 11 hereditary cancers
Identifies actionable genomic variants and biomarkers associated with FDA-approved therapies
Identifies HRD status to inform treatment strategies
Identifies prostate cancer aggressiveness to inform treatment strategies
Identifies risk of developing 11 hereditary cancers leveraging family history of certain cancers
Identifies at-risk couples for a pregnancy affected by inherited conditions
Identifies risk of chromosomal conditions for expectant parents
Identifies fetal sex as early as six weeks into pregnancy
Identifies how genes affect outcomes with certain mental health medications